These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27513862)

  • 1. Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization.
    Gaide O; Clayton H; Girardin M; Kuonen F
    Dermatology; 2016; 232 Suppl 1():7-8. PubMed ID: 27513862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient.
    Mühlstädt M
    Dermatology; 2016; 232 Suppl 1():20-3. PubMed ID: 27513345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
    Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
    J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
    Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
    Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
    Stockfleth E; Bastian M
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
    Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).
    Kim YC; Yang JY; Yoon JS; Jo SJ; Ahn HH; Song KH; Lee DY; Chung KY; Won YH; Kim IH
    Br J Dermatol; 2018 Oct; 179(4):836-843. PubMed ID: 29355904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Philipp-Dormston WG
    Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple cutaneous squamous cell carcinoma after treatment with ingenol mebutate].
    Chabbert C; Levy M; Legrand L
    Ann Dermatol Venereol; 2019 Dec; 146(12):823-825. PubMed ID: 31526534
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
    Berman B
    Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bowenoid Actinic Keratosis and Bowen's Disease Treated Successfully with Ingenol Mebutate.
    Mohanna MT; Hofbauer GF
    Dermatology; 2016; 232 Suppl 1():14-6. PubMed ID: 27513957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local skin reactions following the administration of topical ingenol mebutate for actinic keratosis.
    Conde-Taboada A; Mercado B; Aranegui B; González-Guerra E; López-Bran E
    Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
    Bettencourt MS
    J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization.
    Kostovic K; Gulin SJ; Mokos ZB; Ceovic R
    Anticancer Agents Med Chem; 2017; 17(10):1304-1311. PubMed ID: 28270072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosis.
    Jim On SC; Haddican M; Yaroshinsky A; Singer G; Lebwohl M
    Cutis; 2015 Jan; 95(1):47-51. PubMed ID: 25671445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.
    Elías I; Ortega-Joaquín N; de la Cueva P; Del Pozo LJ; Moreno-Ramírez D; Boada A; Aguilar M; Mirada A; Mosquera E; Gibbons C; Oyagüez I
    Actas Dermosifiliogr; 2016; 107(6):498-508. PubMed ID: 27130804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
    Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
    JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ingenol mebutate-mediated reduction in p53-positive keratinocytes in skin cancerization field directly correlates with clinical response in patients with multiple actinic keratoses.
    Grandi V; di Gennaro P; Torrigiani S; Basco L; Lastrucci I; Pimpinelli N
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1297-1303. PubMed ID: 30801837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.